1st | 논문 |
2021년 9월 26일 김규원 김예일 김현수 안태영 | - Anti-senescent drug screening by deep learning-based morphology senescence scoring - Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages - Cancer selective target degradation by folate-caged PROTACs - mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach |
2nd | 논문 |
2021년 11월 14일 김예일 김현수 | - Identification and treatment of T2-low asthma in the era of biologics - Cargo recognition and degradation by selective autophagy |
3rd | 논문 |
2021년 11월 21일 김규원 안태영 | - Mitochondria as a therapeutic target for common pathologies - Engineering precision nanoparticles for drug delivery |
4th | 논문 |
2021년 12월 26일 김예일 김현수 한병우 교수 | - Sweet death: fructose as a metabolic toxin that targets the gut-liver axis - Targeted degradation of oncogenic KRAS-G12C by VHL-recruiting PROTACs |
5th | 논문 |
2022년 1월 9일 안시현 안이진 | - mRNA vaccines for infectious diseases: principles, delivery and clinical translation - Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells |
6th | 논문 |
2022년 1월 23일 성지윤 안태영 임태환 차혁진 교수 | - Genome-editing-mediated restructuring of tumor immune microenvironment for prevention of metastasis - Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR-T cell engineering - Synaptic adhesion molecule IgSF11 regulates synaptic transmission and plasticity |
7th | 논문 |
2022년 2월 19일 김예일 안이진 이나영 박사 | - Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome - COVID-19 and liver disease: mechanistic and clinical perspectives |
8th | 논문 |
2022년 3월 6일 김규원 임태환 | - The adaptive immune system is a major driver of selection for tumor suppressor gene inactivation - Bispecific antibodies: a mechanistic review of the pipeline |
9th | 논문 |
2022년 3월 20일 안시현 안태영 | - Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis - Hyaluronic acid-bilirubiin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis |
10th | 논문 |
2022년 4월 3일 김현수 성지윤 | - Advances in protein structure prediction and design - A novel nanoprobe for targeted imaging and photothermal/photodynamic therapy of lung cancer |
11th | 논문 |
2022년 5월 1일 박희준 이승준 | - Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing - A decade of iontronic delivery devices |
12th | 논문 |
2022년 5월 15일 임호균 홍채영 | - A basic insight into aptamer-drug conjugates (ApDCs) - Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease |
13th | 논문 |
2022년 6월 26일 변재인 임태환 | - Cell-type specific Shank2 deletion in mice leads to differential synaptic and behavioral phenotypes - The renaissance of chemically generated bispecific antibodies |
14th | 논문 |
2022년 7월 3일 안이진 백진식 | - Third generation EGFR TKIs: current data and future directions - Endolysin, a Promising Solution against Antimicrobial Resistance |
15th | 논문 |
2022년 7월 17일 김예일 안시현 | - Targeting mitochondria-located circRNA SCAR alleviates NASH via reducing mROS output - The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K |
16th | 논문 |
2022년 7월 24일 안태영 | - Inducing immune tolerance with dendritic cell-targeting nanomedicines |
17th | 논문 |
2022년 7월 31일 김현수 박희준 | - Predicting substrates of the human breast cancer resistance protein using a support vector machine method - Biased allosteric modulators: new frontiers in GPCR drug discovery |
18th | 논문 |
2022년 8월 7일 성지윤 이승준 | - Near-infrared light triggered nanobomb for in situ on-demand maximization of photothermal/photodynamic efficacy for cancer therapy - Metabolic mechanisms of a drug revealed by distortion-free 13C tracer analysis |
19th | 논문 |
2022년 8월 14일 임호균 홍채영 | - Discovery of selective RNA-binding small molecules by affinity-selection mass spectrometry - Discovery and synthesis of a pyrimidine-based Aurora Kinase inhibitor to reduce levels of MYC oncoproteins |
20th | 논문 |
2022년 8월 21일 변재인 임태환 배낙현 박사 | - A specific amyloid-beta assembly in the brain impairs memory - The renaissance of chemically generated bispecific antibodies |
21st | 논문 |
2022년 8월 28일 안이진 백진식 신상 박사 | - Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling - Molecular therapies and precision medicine for hepatocellular carcinoma |
22nd | 논문 |
2022년 9월 15일 김예일 김현수 | - Fragment-based covalent ligand discovery - FGF21: An emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases |
23rd | 논문 |
2022년 9월 19일 김규원 임태환 | - NAD+ metabolism and its roles in cellular processes during ageing - A cytokine receptor masked IL2 prodrug selectively activates tumor infiltrating lymphocytes or potent antitumor therapy |
24th | 논문 |
2022년 10월 3일 임호균 홍채영 | - The tumor microenvironment in pancreatic cancer – clinical challenges and opportunities - Non-coding RNA networks in cancer |
25th | 논문 |
2022년 10월 31일 변재인 안선우 | - Noninvasive optical activation of Flp recombinase for genetic manipulation in deep mouse brain regions - Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway |